Nurse Practitioner, Acute Care · Orange, CA
NPI
1932334745
Since 2009
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
101 the City Dr S
Orange, CA, 92868
Phone (714) 880-7812
Groups this clinician bills Medicare through
Medicare paid, 2024
$160K
8,021 services
Medicare patients, 2024
121
Average age 75
Drug cost, 2024
$517K
857 prescriptions
Company payments, 2025
$3,842
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sara Cooper was code J0897 (injection, denosumab, 1 mg), 4,380 times for 20 patients. In total Sara Cooper billed 8,021 services in 15 codes, and Medicare paid $160K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,380 | 20 | $20.29 | $89K |
| J9395 Injection, fulvestrant, 25 mg | Office | 2,490 | 25 | $6.16 | $15K |
| 96402 Chemotherapy Administration | Office | 267 | 30 | $25.95 | $6,930 |
| 99214 Office E&M - Established | Office | 241 | 97 | $89.76 | $22K |
| 36415 Venipuncture Blood Collection | Office | 101 | 40 | $5.88 | $594 |
| 96372 Injection Administration | Office | 54 | 24 | $10.07 | $544 |
| 99213 Office E&M - Established | Office | 49 | 31 | $65.56 | $3,213 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 32 | 31 | $11.32 | $362 |
| 99215 Office E&M - Established | Office | 18 | 12 | $124.26 | $2,237 |
By year: 2022 $40K for 844 services; 2023 $154K for 8,161 services; 2024 $160K for 8,021 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 101 | 40 | $5.88 | $594 |
Medicare prescription drug claims, 2024
In 2024, the drug Sara Cooper prescribed most often to Medicare patients was Tamoxifen Citrate, with 290 prescriptions and refills. In total Sara Cooper wrote 857 Medicare prescriptions that cost $517K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamoxifen Citrate Generic | 290 | 652 | 93 | $4,798 |
| Raloxifene Hcl Generic | 153 | 407 | 50 | $8,776 |
| Anastrozole Generic | 36 | 86 | 16 | $721 |
| Exemestane Generic | 28 | 66 | Under 11 | $5,660 |
| Estradiol Generic | 24 | 57 | Under 11 | $1,174 |
| Ondansetron Odt Ondansetron | 22 | 22 | Under 11 | $284 |
| Duavee Estrogens,conj/Bazedoxifene | 21 | 30 | Under 11 | $5,801 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 21 | 43 | Under 11 | $731 |
| Ondansetron Hcl Generic | 21 | 21 | 15 | $204 |
| Truqap Capivasertib | 18 | 18 | Under 11 | $302K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 17 | 33 | Under 11 | $297 |
| Letrozole Generic | 15 | 37 | Under 11 | $331 |
| Alprazolam Generic | 12 | 14 | Under 11 | $106 |
| Zolpidem Tartrate Generic | 11 | 11 | Under 11 | $75.22 |
Brand drugs: 82 claims; generic drugs: 775 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sara Cooper $3,842 ($3,842 in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $3,621.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $3,621 |
| Abbott Laboratories ABT | 2 | $42.01 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $38.73 |
| Boston Scientific Corporation BSX | 1 | $31.72 |
| Gilead Sciences, Inc. GILD | 1 | $26.87 |
| Daiichi Sankyo Inc. 4568.T | 1 | $24.44 |
| Averitas Pharma Inc. | 1 | $22.67 |
| Recordati_rare_diseases_inc. | 1 | $20.31 |
| Almatica Pharma LLC | 1 | $13.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.